Literature DB >> 1400920

Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type.

J V Haxby1, K Raffaele, J Gillette, M B Schapiro, S I Rapoport.   

Abstract

The course of decline was studied in 16 patients with probable or definite dementia of the Alzheimer type (DAT) over 2.7 to 6.8 years from first to last evaluation. Overall severity of dementia was measured with the Wechsler Adult Intelligence Scale (WAIS), the Dementia Rating Scale (DRS), and the Mini-Mental State Examination (MMSE), at approximately annual intervals. An initial plateau phase, during which language and cognitive functions did not change for periods of 9 to 35 months, was observed in 5 patients who initially had an isolated memory impairment without significant impairment of nonmemory language or visuospatial function. Once nonmemory functions began to decline, the rate of decline was remarkably steady in most individual patients but varied markedly among patients. The initial rate of decline after the plateau phase, as measured with the WAIS and DRS, was a significant predictor of subsequent rate in individual patients (r = .66, p less than .01, and r = .67, p less than .01, for the WAIS and DRS, respectively). The MMSE was a less reliable measure of longitudinal change in dementia severity and did not predict future rates of decline (r = .29). These results demonstrate a biphasic trajectory of decline in patients with DAT. Stable interindividual differences in rate of decline may provide a basis for designing more sensitive studies of treatments intended to slow or halt the progress of DAT.

Entities:  

Mesh:

Year:  1992        PMID: 1400920     DOI: 10.1080/01688639208402846

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  12 in total

1.  A Bayesian Disease Progression Model for Clinical Trajectories.

Authors:  Yingying Zhu; Mert R Sabuncu
Journal:  Graphs Biomed Image Anal Integr Med Imaging Nonimaging Modalities (2018)       Date:  2018-09-16

2.  Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study.

Authors:  Kazumasa Kume; Haruo Hanyu; Tomohiko Sato; Kentaro Hirao; Soichiro Shimizu; Hidekazu Kanetaka; Hiofumi Sakurai; Toshihiko Iwamoto
Journal:  J Neurol       Date:  2011-02-17       Impact factor: 4.849

3.  Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach.

Authors:  Rochelle E Tractenberg; Paul S Aisen; Myron F Weiner; Jeffrey L Cummings; Gregory R Hancock
Journal:  Alzheimers Dement       Date:  2006-10       Impact factor: 21.566

4.  Differential longitudinal decline on the Mini-Mental State Examination in frontotemporal lobar degeneration and Alzheimer disease.

Authors:  Kay See Tan; David J Libon; Katya Rascovsky; Murray Grossman; Sharon X Xie
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Oct-Dec       Impact factor: 2.703

Review 5.  Neurogenesis and Alzheimer's disease: at the crossroads.

Authors:  Orly Lazarov; Robert A Marr
Journal:  Exp Neurol       Date:  2009-08-19       Impact factor: 5.330

6.  The effect of education on rCBF changes in Alzheimer's disease: a longitudinal SPECT study.

Authors:  Haruo Hanyu; Tomohiko Sato; Soichiro Shimizu; Hidekazu Kanetaka; Toshihiko Iwamoto; Kiyoshi Koizumi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-12       Impact factor: 9.236

7.  Education and rates of cognitive decline in incident Alzheimer's disease.

Authors:  N Scarmeas; S M Albert; J J Manly; Y Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

8.  The natural history of cognitive decline in Alzheimer's disease.

Authors:  Robert S Wilson; Eisuke Segawa; Patricia A Boyle; Sophia E Anagnos; Loren P Hizel; David A Bennett
Journal:  Psychol Aging       Date:  2012-09-03

Review 9.  Therapy for Alzheimer's disease. Symptomatic or neuroprotective?

Authors:  E Giacobini
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

10.  Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study.

Authors:  Andrew J Lawrence; Rebecca L Brookes; Eva A Zeestraten; Thomas R Barrick; Robin G Morris; Hugh S Markus
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.